Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.lfs.2021.120111

http://scihub22266oqcxt.onion/10.1016/j.lfs.2021.120111
suck pdf from google scholar
34732330!8557391!34732330
unlimited free pdf from europmc34732330    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid34732330      Life+Sci 2022 ; 291 (ä): 120111
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Nrf2/Keap1/ARE signaling: Towards specific regulation #MMPMID34732330
  • Ulasov AV; Rosenkranz AA; Georgiev GP; Sobolev AS
  • Life Sci 2022[Feb]; 291 (ä): 120111 PMID34732330show ga
  • The Nrf2 transcription factor governs the expression of hundreds genes involved in cell defense against oxidative stress, the hallmark of numerous diseases such as neurodegenerative, cardiovascular, some viral pathologies, diabetes and others. The main route for Nrf2 activity regulation is via interactions with the Keap1 protein. Under the normoxia the Keap1 binds the Nrf2 and targets it to the proteasomal degradation, while the Keap1 is regenerated. Upon oxidative stress the interactions between Nrf2 and Keap1 are interrupted and the Nrf2 activates the transcription of the protective genes. Currently, the Nrf2 system activation is considered as a powerful cytoprotective strategy for treatment of different pathologies, which pathogenesis relies on oxidative stress including viral diseases of pivotal importance such as COVID-19. The implementation of this strategy is accomplished mainly through the inactivation of the Keap1 "guardian" function. Two approaches are now developing: the Keap1 modification via electrophilic agents, which leads to the Nrf2 release, and direct interruption of the Nrf2:Keap1 protein-protein interactions (PPI). Because of theirs chemical structure, the Nrf2 electrophilic inducers could non-specifically interact with others cellular proteins leading to undesired effects. Whereas the non-electrophilic inhibitors of the Nrf2:Keap1 PPI could be more specific, thereby widening the therapeutic window.
  • |*Oxidative Stress[MESH]
  • |Angiotensin-Converting Enzyme 2/metabolism[MESH]
  • |Animals[MESH]
  • |Antioxidant Response Elements/*physiology[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19/metabolism[MESH]
  • |Host-Pathogen Interactions/physiology[MESH]
  • |Humans[MESH]
  • |Kelch-Like ECH-Associated Protein 1/*metabolism[MESH]
  • |Molecular Targeted Therapy/*methods[MESH]
  • |NF-E2-Related Factor 2/*metabolism[MESH]
  • |Ozone/therapeutic use[MESH]
  • |Protein Interaction Maps/drug effects[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box